110332 ⎘
Reverse transcribing RNA viruses; Details; Retroviridae; Gammaretrovirus, e.g. murine leukeamia virus Virus like particles [VLP]
METHODS AND PRODUCTS FOR GENETIC ENGINEERING
#2COMPOSITIONS AND METHODS FOR EFFICIENT IN VIVO DELIVERY
#3COMPOSITIONS AND METHODS FOR EFFICIENT IN VIVO DELIVERY
#4COMPOSITIONS AND METHODS FOR EFFICIENT IN VIVO DELIVERY
#5SELF-ASSEMBLING VIRUS-LIKE PARTICLES FOR DELIVERY OF PRIME EDITORS AND METHODS OF MAKING AND USING SAME
#6COMPOSITIONS AND METHODS FOR EFFICIENT IN VIVO DELIVERY
#7METHODS AND PRODUCTS FOR GENETIC ENGINEERING
#8METHODS AND PRODUCTS FOR GENETIC ENGINEERING
#9Methods and products for genetic engineering
#10VLP-based bivalent Ebola vaccines and methods of making and using same
#11Methods and products for genetic engineering
#12COMPOSITIONS AND METHODS FOR TREATMENT OF CYTOMEGALOVIRUS
#13COMPOSITIONS AND METHODS FOR DELIVERING CARGO TO A TARGET CELL
#14AFFINITY-BASED MULTIPLEXING FOR LIVE-CELL MONITORING OF COMPLEX CELL POPULATIONS
#15VLP-based bivalent ebola vaccines and methods of making and using same
#16VIRUS-LIKE PARTICLES WHICH CAN BE USED IN THE TREATMENT OF ALLERGIES
#17Methods and products for genetic engineering
#18Virus-like particles which can be used in the treatment of autoimmune diseases
#19Method of inhibiting enveloped virus binding to target cells by incorporating P-selectin glycoprotein ligand-1 (PSGL-1) into virions
#20VLP-BASED MONOVALENT EBOLA VACCINES AND METHODS OF MAKING AND USING SAME
#21Methods and products for genetic engineering
#22Vaccine compositions for treatment of Zika virus
#23Compositions and methods for treatment of cytomegalovirus
#24Fusion proteins and uses thereof
#25IMMUNOSUPPRESSIVE COMPONENTS ASSOCIATED WITH RETROVIRAL REPLICATING VECTORS
#26Compositions and methods for treatment of cytomegalovirus
#27Synthetic viruses and uses thereof
#28Pharmaceutical compositions comprising a polypeptide comprising at least one CXXC motif and heterologous antigens and uses thereof
#29Method for the production of antibodies that bind to multiple membrane spanning proteins
#30Virus-Like Particle Mediated Cellular Delivery
#31Use of mTOR inhibitors to enhance T cell immune responses
#32Method for the preparation of virus-like particles (VLPS) comprising heterologous multiple membrane spanning proteins
#33Chimeric influenza virus-like particles
#34VIROSOMES, METHODS OF PREPARATION, AND IMMUNOGENIC COMPOSITIONS
#35CHIMERIC VIRUS-LIKE PARTICLES
#36Novel sequences encoding hepatitis C virus glycoproteins
#37Host Cells Containing Multiple Integrating Vectors
#38High-titer retroviral packaging cells
#39Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins
#40Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics
#41Virus-like particles, methods of preparation, and immunogenic compositions
#42Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics
#43Sequences encoding hepatitis C virus glycoproteins
#44Packaging cells
#45Host cells containing multiple integrating vectors
#46Vaccine compositions for treatment of Zika virus